CARDIOPULMONARY BYPASS EQUIPMENT MARKET ANALYSIS

Key Developments

• On January 9, 2024, Inspira Technology, a specialty medical device company,  launched a single-use disposable blood oxygenation kit. This kit, currently in development for its INSPIRA ART medical device series, is also being engineered to work seamlessly with other life support machines, including specific cardio-pulmonary bypass devices. By aiming to reduce costs and enhance efficiency in hospital budgets, this initiative represents a forward-looking approach to medical innovation.
• In March 2023, LivaNova, a medical device manufacturer, received FDA clearance for its Essenz Heart-Lung Machine (HLM), marking the launch of the Essenz Perfusion System in the U.S. This system, inclusive of the Essenz Patient Monitor, offers a patient-specific perfusion approach driven by data, enhancing clinical workflows and patient care during cardiopulmonary bypass procedures.